IL89881A - Calcitonin peptides whose nature is differentiated by a sugar molecule, their preparation and pharmaceutical preparations containing them - Google Patents

Calcitonin peptides whose nature is differentiated by a sugar molecule, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL89881A
IL89881A IL8988189A IL8988189A IL89881A IL 89881 A IL89881 A IL 89881A IL 8988189 A IL8988189 A IL 8988189A IL 8988189 A IL8988189 A IL 8988189A IL 89881 A IL89881 A IL 89881A
Authority
IL
Israel
Prior art keywords
thr
leu
residue
ser
lys
Prior art date
Application number
IL8988189A
Other languages
English (en)
Hebrew (he)
Other versions
IL89881A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL89881A0 publication Critical patent/IL89881A0/xx
Priority to IL105512A priority Critical patent/IL105512A0/xx
Publication of IL89881A publication Critical patent/IL89881A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL8988189A 1988-04-08 1989-04-07 Calcitonin peptides whose nature is differentiated by a sugar molecule, their preparation and pharmaceutical preparations containing them IL89881A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL105512A IL105512A0 (en) 1988-04-08 1993-04-23 Lhrh antagonist peptides modified by sugar molecules,their production and pharmaceutical compositions containing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (2)

Publication Number Publication Date
IL89881A0 IL89881A0 (en) 1989-12-15
IL89881A true IL89881A (en) 1994-05-30

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8988189A IL89881A (en) 1988-04-08 1989-04-07 Calcitonin peptides whose nature is differentiated by a sugar molecule, their preparation and pharmaceutical preparations containing them

Country Status (19)

Country Link
US (1) US5541159A (ja)
JP (2) JPH01305099A (ja)
AT (1) ATA900689A (ja)
AU (2) AU3362889A (ja)
BE (1) BE1004357A4 (ja)
CH (1) CH682152A5 (ja)
DK (1) DK163689A (ja)
ES (1) ES2015645A6 (ja)
FR (1) FR2629825B1 (ja)
GB (1) GB2218102B (ja)
IE (1) IE930109L (ja)
IL (1) IL89881A (ja)
IT (1) IT1235894B (ja)
LU (1) LU87495A1 (ja)
MY (1) MY108554A (ja)
NL (1) NL8900864A (ja)
NZ (1) NZ228677A (ja)
SE (1) SE8901241L (ja)
WO (1) WO1989009786A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DE59100945D1 (de) * 1990-08-04 1994-03-10 Hoechst Ag Gonadoliberin-Antagonisten.
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
WO1993016087A2 (en) * 1992-02-13 1993-08-19 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
WO1994028015A1 (en) * 1993-05-20 1994-12-08 Biotech Australia Pty. Limited Lhrh antagonists
SI9420051A (en) * 1993-08-09 1996-12-31 Biomeasure Inc Chemical modified peptide derivatives, process for their preparation and their use in human therapy
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
DE69737769T2 (de) 1996-07-25 2008-05-15 Biogen Idec Ma Inc., Cambridge Molekülmodell für vla-4-inhibitoren
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
JP4372345B2 (ja) 1998-02-13 2009-11-25 アミリン・ファーマシューティカルズ，インコーポレイテッド 新規な混合アミリン活性化合物
NZ509199A (en) 1998-05-28 2003-10-31 Biogen Inc A VLA-4 inhibitor: oMePUPA-V
CZ2002518A3 (cs) 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater

Also Published As

Publication number Publication date
GB2218102B (en) 1992-09-16
AU3362889A (en) 1989-11-03
US5541159A (en) 1996-07-30
ATA900689A (de) 1997-01-15
DK163689A (da) 1989-10-30
CH682152A5 (ja) 1993-07-30
IT1235894B (it) 1992-11-23
FR2629825B1 (fr) 1993-05-14
JPH01305099A (ja) 1989-12-08
NL8900864A (nl) 1989-11-01
GB8907652D0 (en) 1989-05-17
SE8901241D0 (sv) 1989-04-07
GB2218102A (en) 1989-11-08
BE1004357A4 (fr) 1992-11-10
LU87495A1 (fr) 1989-11-14
FR2629825A1 (fr) 1989-10-13
IT8947823A0 (it) 1989-04-07
IL89881A0 (en) 1989-12-15
JPH0789994A (ja) 1995-04-04
NZ228677A (en) 1994-08-26
AU3263789A (en) 1989-10-12
DK163689D0 (da) 1989-04-05
SE8901241L (sv) 1990-02-02
IE930109L (en) 1989-10-08
WO1989009786A1 (en) 1989-10-19
MY108554A (en) 1996-10-31
ES2015645A6 (es) 1990-09-01
AU623385B2 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
IL89881A (en) Calcitonin peptides whose nature is differentiated by a sugar molecule, their preparation and pharmaceutical preparations containing them
KR960016861B1 (ko) 펩티드 유도체 및 이의 제조방법
US3929758A (en) Cyclization of cysteine-containing peptides
US4758550A (en) Calcitonin derivatives
CA2069943A1 (en) Synthetic calcitonin peptides
US4490364A (en) CCK Agonists II
HUT61579A (en) Process for producing polypeptides and pharmaceutical compositions with anti-hiv activity, comprising same as active ingredient
US4293455A (en) N.sup.α -Desacetylthymosinα1 and process
US4320118A (en) Deca-, undeca-, dodeca- and tridecapeptides with thymic activity
EP0181121B1 (en) Novel polypeptide and process for producing the same
Boissonnas et al. Chemistry of the neurohypophysial hormones
Gobbo et al. Synthesis and biological activity of some linear and cyclic kinin analogues
US4820804A (en) Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
EP0314866A2 (en) Novel alkylated hormonereleasing peptides and method of treating mammals therewith
GB2246782A (en) LHRH peptide derivatives
SIVANANDAIAH et al. Synthesis and biological studies of dermorphin and its analogs substituted at positions 5 and 7
Wünsch et al. Synthesis of human des-tryptophan-1, norleucine-12-minigastrin-II and its biological activities
Buku et al. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin
JPS63225399A (ja) ペプチド誘導体およびその製造法
DE3790635B4 (de) Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür
GB2233652A (en) Synthesis of peptide alcohols
FR2682680A1 (fr) Derives peptidiques d'antagonistes de la lr-rh, leur preparation et leur utilisation comme medicaments.
HEMMASI et al. Synthesis of the C-terminal undeca-and protected docosapeptide of bovine insulin B-chain
Abiko et al. Synthesis of [Phe (4F) 3] thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients
FUNAKOSHI et al. Studies on Peptides. CL. Syntheses of [D-His2]-Analogs of Enkephalin and Adrenorphin and Several [D-Arg2] enkephalin Analogs

Legal Events

Date Code Title Description
RH Patent void